Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
12/2010
12/08/2010CN101910164A Diamido thiazole derivatives as protein kinase inhibitors
12/08/2010CN101910163A Heterocyclic urea and thiourea derivatives and methods of use thereof
12/08/2010CN101910162A Cyclic pyridyl-N-(1,3,4)-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
12/08/2010CN101910158A Pyridine and pyrazine derivatives useful in the treatment of cell proliferative disorders
12/08/2010CN101910152A 4-pyrazolyl-N-arylpyrimidin-2-amines and 4-pyrazolyl-N-heteroarylpyrimidin-2-amines as janus kinase inhibitors
12/08/2010CN101910145A Heterocyclic antiviral compounds
12/08/2010CN101910143A Condensed aminodihydrothiazine derivative
12/08/2010CN101910142A Modulators for amyloid beta
12/08/2010CN101910133A Heterocycle phenyl amide T-type calcium channel antagonists
12/08/2010CN101910121A Bis-(sulfonylamino) derivatives in therapy 066
12/08/2010CN101906099A Method for biochemically synthesizing epothilone D-lactam derivatives
12/07/2010USRE41990 epothilone derivatives used for the treatment of cancer and cancers which have developed a multidrug-resistant phenotype; anticarcinogenic agents
12/07/2010US7847101 such as (4-Benzothiazol-2-yl-1H-pyrazol-3-yl)-[2-(1H-imidazol-4-yl)-ethyl]-amine, used in the treatment of disorders associated with hyperproliferation and tissue remodelling or repair, inflammation, cell migration and invasion, and renal diseases, or as protein kinase inhibitors
12/07/2010US7846962 3-(5-tert-Butyl-2-Hydroxy-phenyl)-3-phenyl-1,3-dihydro-indol-2-one and/or its derivatives, used for the treatment of cellular proliferative disorders, non-proliferative, degenerative disorders, viral infections, and/or disorders associated with viral infections
12/07/2010US7846952 epothilone derivatives in combination with carriers or diluents, used for plant protection in agriculture, forestry or horticulture; plant safening agents
12/07/2010US7846951 treating cystic fibrosis, emphysema, or chronic obstructive pulmonary disease, comprising administering to a patient azole-4-carboxamide derivatives such as N,N-dibenzyl-2-[(2,6-dichlorophenyl)methyl]-1,3-thiazole-4-carboxamide
12/07/2010US7846950 Histamine H3 receptor inhibitors, preparation and therapeutic uses
12/07/2010US7846945 2-[4-Chloro-3-(4-hydroxy-benzyl)-phenyl]-6-methoxy-tetrahydro-pyran-3,4,5-triol; 2-[4-Chloro-3-(4-ethoxy-benzyl)-phenyl]-3,4,5-trihydroxy-piperidine-1-carboxylic acid methyl ester; (2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-methoxytetrahydro-2H-thiopyran-3,4,5-triol; antidibetic, antiobesity agents
12/07/2010US7846925 such as 5-(1,3-benzodioxol-5-ylmethylene)-1,3-thiazolidine-2,4-dione, used for the treatment and/or prophylaxis of autoimmune, cardiovascular or neurodegenerative disorders, inflammatory or kidney diseases, bacterial or viral infections, platelet aggregation, cancer, transplant rejection or lung injuries
12/07/2010US7846922 1-(isopropyl)-4-{[4-(tetrahydro-2H-pyran4-yloxy)phenyl]carbonyl}hexahydro-1H-1,4-diazepine, used in the treatment of nervous system and psychological disorders such as Alzheimer's disease or as cognition activators
12/07/2010CA2583084C 7,8-bicycloalkyl-chroman derivatives
12/07/2010CA2440111C Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative
12/07/2010CA2434203C 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
12/07/2010CA2374995C Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
12/02/2010WO2010138790A1 Antiviral compounds composed of three aligned aryl moieties to treat diseases such as hepatitis c
12/02/2010WO2010138578A1 Pyrimidine inhibitors of kinase activity
12/02/2010WO2010138490A1 Benzoxazepines as inhibitors of mtor and methods of their use and manufacture
12/02/2010WO2010138487A1 BENZOXAZEPINES AS INHIBITORS OF PI3K/m TOR AND METHODS OF THEIR USE AND MANUFACTURE
12/02/2010WO2010137351A1 Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
12/02/2010WO2010137350A1 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
12/02/2010WO2010137349A1 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
12/02/2010WO2010137302A1 Nitrogen-containing heteroaryl derivatives and fungicides for agricultural and horticultural use
12/02/2010WO2010136138A1 Substituted piperidines
12/02/2010WO2010136128A1 Substituted piperidines
12/02/2010WO2010136109A1 Materials for organic electroluminescent devices
12/02/2010WO2009118596A3 Phthalimide derivatives as trpa1 modulators
12/02/2010US20100305174 Novel Heterocyclic Derivatives
12/02/2010US20100305133 Prolyl Hydroxylase Inhibitors
12/02/2010US20100305118 Pyrimidine inhibitors of kinase activity
12/02/2010US20100305112 Pyrimidine inhibitors of kinase activity
12/02/2010US20100305100 Methods for treating hepatitis c
12/02/2010US20100305097 N-benzyl-4-methyleneamino-3-hydroxy-2-pyridones
12/02/2010US20100305073 Amide compounds as boosters of antivirals
12/02/2010US20100305070 Treatment or prophylaxis of proliferative conditions
12/02/2010US20100305067 Antibacterial condensed thiazoles
12/02/2010CA2763633A1 Pyrimidine inhibitors of kinase activity
12/02/2010CA2763386A1 Substituted piperidines
12/02/2010CA2763370A1 Substituted piperidines
12/02/2010CA2763008A1 Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and manufacture
12/02/2010CA2762885A1 Antiviral compounds composed of three aligned aryl moieties to treat diseases such as hepatitis c
12/02/2010CA2762620A1 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
12/02/2010CA2761639A1 Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
12/01/2010EP2256119A1 Vasopressin V1a antagonists
12/01/2010EP2256115A1 Heteromonocyclic compound and use thereof
12/01/2010EP2256105A1 Novel tetrahydroisoquinoline derivative
12/01/2010EP2254888A1 Novel aminopyridine derivatives having aurora a selective inhibitory action
12/01/2010EP2254887A1 Oxazolidinone derivatives
12/01/2010EP2254886A2 3,4-dihydro-2h-pyrazinoý1,2-a¨indol-1-one derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
12/01/2010EP2254878A1 Aldh-2 inhibitors in the treatment of addiction
12/01/2010EP2254410A1 Methods for inhibiting drug degradation
12/01/2010EP1869020B1 Heteroaryl urea derivatives useful for inhibiting chk1
12/01/2010EP1487442B1 Thiazolidine carboxamide derivatives as modulators of the prostaglandin f receptor
12/01/2010EP1368342B3 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors
12/01/2010CN101903380A 5-aminocyclylmethyl-oxazolidin-2-one derivatives
12/01/2010CN101903378A Aminotriazole derivatives
12/01/2010CN101903373A Functionally selective alpha2c adrenoreceptor agonists
12/01/2010CN101903372A Heteroaryl derivatives as orexin receptor antagonists
12/01/2010CN101903357A Cyclic amine substituted pyrimidinediamines as PKC inhibitors
12/01/2010CN101903351A 病毒聚合酶抑制剂 Viral polymerase inhibitors
12/01/2010CN101903349A 4-(4-pyridinyl)-benzamides and their use as ROCK activity modulators
12/01/2010CN101903347A Piperidinyl and piperazinyl modulators of gamma-secretase
12/01/2010CN101903339A Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
12/01/2010CN101902912A Fungicidal amines
12/01/2010CN101899042A 4-substituted-1,2,3-thiadiazole formoxyl ureide compound, preparation method and application thereof
12/01/2010CN101899039A Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
12/01/2010CN101899010A Quinazol derivative, preparation method and application thereof
12/01/2010CN101898996A Organic material and application thereof to organic electroluminescent devices
11/2010
11/30/2010US7842816 Mitogen-activated protein kinase kinase inhibitors such as 2-amino-3-methylbutyric acid 2-{[6-(4-bromo-2-chlorophenylamino)-7-fluoro-3-methyl-3H -benzoimidazole-5-carbonyl]-aminooxy}-ethylester, used for the treatment of diseases, such as cancer and inflammation in mammals
11/30/2010US7842813 for synthesis of erythromycin derivatives; reacting thionyl chloride with 6-hydroxylmethyl-nicotinic acid methyl ester to provide 6-chloromethyl-nicotinic acid methyl ester, chlorinating, reacting with ammonia or ammonium hydroxide, sulfiding
11/30/2010US7842704 Biphenyl-2-ylcarbamic Acid 1-{9-[2-(4-Hydroxy-2-oxo-2,3-dihydrobenzothiazol-7-yl)-ethylamino]nonyl}piperidin-4-yl Ester Bis(trifluoroacetate) Salt; chronic obstructive pulmonary disease, asthma; bronchodilators
11/30/2010US7842686 Calcitonin gene-related peptide (CGRP) receptor antagonists, such as 2-(2-Butyl-3-oxo-2H-benzo[b][1,4]thiazin-4(3H)-yl)-N-(2,5-dioxo-1',3'-dihydrospiro[imidazolidine-4,2'-indene]-5'-yl)acetamide, used as analgesics
11/30/2010CA2607499C Histamine-3 receptor antagonists
11/30/2010CA2583492C Naphthalene and isoquinoline derivatives bearing a pyridyl group for the treatment of skin lesions
11/30/2010CA2519938C Prostaglandin analogs as ep4 receptor agonists
11/30/2010CA2482858C Tricyclic thrombin receptor antagonists
11/30/2010CA2432809C Heteroaryl urea neuropeptide y y5 receptor antagonists
11/30/2010CA2335477C Sulfonamide inhibitors of aspartyl protease
11/25/2010WO2010135568A1 Benzoxazepines as inhibitors of mtor and their use to treat cancer
11/25/2010WO2010135524A1 Benzoxazepines based p13k/mt0r inhibitors against proliferative diseases
11/25/2010WO2010135014A1 Tri-cyclic pyrazolopyridine kinase inhibitors
11/25/2010WO2010133534A1 Bicyclic amino substituted compounds as pi3k inhibitors
11/25/2010WO2010133312A1 Halogen-substituted compounds as pesticides
11/25/2010WO2010132999A1 Methyl sulfanyl pyrmidmes useful as antiinflammatories, analgesics, and antiepileptics
11/25/2010WO2010132951A1 Oligothiophenes and uses thereof in photovoltaic devices
11/25/2010WO2010106436A3 Novel anti-inflammatory agents
11/25/2010WO2010081036A3 Fluorine containing compounds and methods of use thereof
11/25/2010WO2009132202A3 Macrocyclic compounds and their use as kinase inhibitors
11/25/2010US20100298558 Substituted dihydroazole compound and pest control agent
11/25/2010US20100298390 Inhibition of lethal factor protease activity from anthrax toxin
11/25/2010US20100298389 Novel Imaging Tracers for Early Detection and Treatment of Amyloid Plaques Caused by Alzheimer's Disease and Related Disorders
1 ... 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 ... 628